TriSalus Life Sciences
TLSI
60 hedge funds and large institutions have $44.6M invested in TriSalus Life Sciences in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 2 closing their positions.
650% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 2
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
25% more funds holding
Funds holding: 48 → 60 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $46.8M → $44.6M (-$2.25M)
3.48% less ownership
Funds ownership: 22.7% → 19.22% (-3.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.62M |
| 2 |
BlackRock
New York
|
+$778K |
| 3 |
Goldman Sachs
New York
|
+$626K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$465K |
| 5 |
State Street
Boston,
Massachusetts
|
+$361K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$215K |
| 2 |
Morgan Stanley
New York
|
-$180K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$112K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$105K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$36.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $1.67K | -$23.7K | -5,068 | -93% |
|
52
Fidelity Investments
Boston,
Massachusetts
| $1.19K | +$1.2K | +256 | New |
|
|
S
53
SignatureFD
Atlanta,
Georgia
| $465 | – | – | – |
|
|
EWA
54
EverSource Wealth Advisors
Birmingham,
Alabama
| $446 | +$449 | +96 | New |
|
55
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $302 | +$304 | +65 | New |
|
|
EP
56
Essential Partners
Rancho Santa Fe,
California
| $102 | +$103 | +22 | New |
|
|
ASN
57
Advisory Services Network
Atlanta,
Georgia
| $33 | +$33 | +7 | New |
|
|
SS
58
SBI Securities
Tokyo,
Japan
| $9 | +$9 | +2 | New |
|
|
IA
59
IFP Advisors
Tampa,
Florida
| $5 | +$5 | +1 | New |
|
|
60
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$112K | -20,558 | Closed |
|
|
61
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$105K | -19,288 | Closed |
|
62
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$421 | +90 | New |
|
TLSI Hedge Fund Activity: Q3 2025 in Review
60 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2025, worth a combined $44.6M — down 4.8% from $46.8M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TLSI positions and 2 closed out — a net gain of 13 holders — while 18 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.62M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $215K.
- 60 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2025, up from 48 in Q2 2025.
- Funds reported $44.6M of TriSalus Life Sciences stock for Q3 2025, down 4.8% quarter-over-quarter.
- 15 funds opened new TriSalus Life Sciences positions in Q3 2025 and 2 closed out, a net change of +13 holders.
- The largest TriSalus Life Sciences buyer in Q3 2025 was Vanguard Group, an estimated $1.62M added.
- The largest TriSalus Life Sciences seller in Q3 2025 was Gilder Gagnon Howe & Co, an estimated $215K sold.
Based on aggregated 13F filings for Q3 2025.